NCT05206201View on ClinicalTrials.gov

A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

January 21, 2022

Study Completion Date

January 21, 2022

Conditions

Malaria

Interventions

DRUG

ZY19489 Capsule

Two part study with single and multiple dose

DRUG

Placebo Capsule

Two part study with single and multiple dose

Trial Locations (1)

382213

Zydus Research Centre, Ahmedabad

All Listed Sponsors

lead

Zydus Lifesciences Limited

INDUSTRY

NCT05206201 - A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects | Biotech Hunter | Biotech Hunter